Severity of psoriasis: time to disentangle severity from symptom control.
作者信息
Geale Kirk, Schmitt-Egenolf Marcus
机构信息
Dermatology, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Quantify Research, Stockholm, Sweden.
出版信息
Br J Dermatol. 2022 Jun;186(6):1033-1034. doi: 10.1111/bjd.21023. Epub 2022 Apr 25.
Abstract
摘要
相似文献
1
Severity of psoriasis: time to disentangle severity from symptom control.银屑病的严重程度：是时候将严重程度与症状控制区分开来了。
Br J Dermatol. 2022 Jun;186(6):1033-1034. doi: 10.1111/bjd.21023. Epub 2022 Apr 25.
2
Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.银屑病面积和严重程度指数与皮肤病生活质量指数评分不一致的斑块状银屑病患者的特征。
J Eur Acad Dermatol Venereol. 2017 May;31(5):e269-e272. doi: 10.1111/jdv.14021. Epub 2016 Nov 14.
3
Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity.银屑病患者的瘙痒严重程度与银屑病疾病严重程度无关。
J Am Acad Dermatol. 2014 Feb;70(2):390-1. doi: 10.1016/j.jaad.2013.09.030.
4
Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.《银屑病症状量表（PSI）的早期发展和内容效度的定性证据：一种银屑病症状严重程度的患者报告结局测量工具》。
J Dermatolog Treat. 2013 Aug;24(4):255-60. doi: 10.3109/09546634.2012.759639. Epub 2013 Jun 20.
5
A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.一项使用儿童皮肤病生活质量指数（CDLQI）评估儿童银屑病的横断面研究：对生活质量有负面影响，且 CDLQI 与严重程度评分中度相关。
Br J Dermatol. 2010 Nov;163(5):1099-101. doi: 10.1111/j.1365-2133.2010.09993.x.
6
[How to evaluate the severity of psoriasis?].[如何评估银屑病的严重程度？]
Ann Dermatol Venereol. 2003 Aug-Sep;130(8-9 Pt 2):843-6.
7
Psoriasis.银屑病
Br J Hosp Med (Lond). 2018 Aug 2;79(8):C114-C117. doi: 10.12968/hmed.2018.79.8.C114.
8
Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.银屑病患者瘙痒、疼痛和脱屑症状的加重与疾病严重程度增加、生活质量下降及工作效率降低相关。
Dermatol Online J. 2015 Oct 16;21(10):13030/qt1x16v3dg.
9
Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.生物制剂治疗的银屑病患者的皮肤病生活质量指数持续改善与银屑病面积和严重程度指数相关：一项纵向研究
Australas J Dermatol. 2016 Aug;57(3):e72-5. doi: 10.1111/ajd.12353. Epub 2015 May 26.
10
Improvement in body surface area is associated with better quality of life among patients with psoriasis in the Corrona Psoriasis Registry.在科罗娜银屑病登记处的银屑病患者中，体表面积的改善与生活质量的提高相关。
J Am Acad Dermatol. 2021 Jun;84(6):1715-1717. doi: 10.1016/j.jaad.2020.08.039. Epub 2020 Aug 13.
引用本文的文献
1
BMI matters: understanding the link between weight and severe psoriasis.体重指数很重要：了解体重与重度银屑病之间的联系。
Sci Rep. 2025 Apr 1;15(1):11158. doi: 10.1038/s41598-025-94505-0.
2
A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.一项在中国开展的大规模回顾性研究探讨了斑块型银屑病严重程度的相关风险因素。
Sci Rep. 2024 Oct 28;14(1):25749. doi: 10.1038/s41598-024-73408-6.
本文引用的文献
1
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations.源自欧洲皮肤病学指南的德国寻常型银屑病治疗S3指南 - 第1部分：治疗目标和治疗建议。
J Dtsch Dermatol Ges. 2021 Jun;19(6):934-150. doi: 10.1111/ddg.14508.
2
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council.银屑病严重程度的再分类：来自国际银屑病理事会的 Delphi 共识。
J Am Acad Dermatol. 2020 Jan;82(1):117-122. doi: 10.1016/j.jaad.2019.08.026. Epub 2019 Aug 16.
3
Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes.用于比较依奇珠单抗与依那西普和安慰剂在中重度斑块状银屑病患者中的疗效的绝对和相对银屑病面积和严重程度指数（PASI）：UNCOVER-2 和 UNCOVER-3 结局的综合分析。
Acta Derm Venereol. 2019 Oct 1;99(11):971-977. doi: 10.2340/00015555-3245.
4
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.美国皮肤病学会-银屑病基金会联合指南：生物制剂治疗银屑病的管理与治疗。
J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13.
5
Definition of treatment goals for moderate to severe psoriasis: a European consensus.中重度银屑病治疗目标的定义：欧洲共识。
Arch Dermatol Res. 2011 Jan;303(1):1-10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21.
6
A new perspective on concepts of asthma severity and control.哮喘严重程度与控制概念的新视角。
Eur Respir J. 2008 Sep;32(3):545-54. doi: 10.1183/09031936.00155307.
7
Current severe psoriasis and the rule of tens.当前的重度银屑病与“十”规则
Br J Dermatol. 2005 May;152(5):861-7. doi: 10.1111/j.1365-2133.2005.06502.x.
Zotero 插件